Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Migraine
- Sponsor
- Cardenal Herrera University
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- Headache Impact Test (HIT-6)
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain.
Detailed Description
The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.
Investigators
Eva Segura Ortí
Eva Segura Ortí (PhD)
Cardenal Herrera University
Eligibility Criteria
Inclusion Criteria
- •Chronic migraine (ICHD_III beta, 2013)
- •Temporomandibular disorders (RDC/TMD)
Exclusion Criteria
- •other neurological disease
- •psychiatric diseases
- •Physical therapy treatment in the last 6 months
- •dental treatment in the last 6 months
- •surgery or trauma in the orofacial region
Outcomes
Primary Outcomes
Headache Impact Test (HIT-6)
Time Frame: 3 months
Secondary Outcomes
- Quality of life (SF-36)(3 months)
- Sleep Quality(3 months)
- Pain catastrophizing scale (PCS)(3 months)
- Craniofacial Pain and Disability Inventory (CF-PDI)(3 months)
- Tampa scale of Kinesiophobia (TSK)(3 months)
- Maximal Mouth Opening pain free(3 months)
- Visual Analogue Scale (VAS)(3 months)
- Pain threshold pressure(3 months)
- Tampa scale of Kinesiophobia of cranio-mandibular disorder (TSK-TCM)(3 months)